Educational Video—The Flexibility Factor

Navigate the discussion with these timestamps: 02:11—Understanding Adaptive Formulation Strategies 04:38—Redefining CDMO Services 05:55—Integration of CDMO and Clinical Services 09:02—Real-Time Adaptation in Clinical Trials 14:21—Clinical Expertise and Infrastructure 16:32—Experience in Adaptive Study Designs 17:34—Comprehensive Support Beyond Phase One 18:19—Regulatory Support and Compliance 19:01—Facility Capabilities and Resources 19:38—Conclusion and Future Directions In early-stage clinical development, speed and adaptability are critical to avoiding costly delays and advancing toward market approval. A “Pharmacy On-Demand” approach enables real-time formulation adjustments during first-in-human studies—so emerging clinical data, not assumptions, determines the optimal dose and excipient mix before scaling up to full GMP manufacturing. The process begins with early formulation work and seamlessly transitions to producing small GMP batches under streamlined “GMP-light” conditions, ready for immediate clinical use. This methodology conserves valuable API, accelerates decision-making, and ensures the formulation moving forward is supported by solid evidence. By maintaining momentum from proof-of-concept through to commercial readiness, this strategy helps drug developers bring therapies to patients faster and with greater confidence. 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗢𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲𝘀:   • Understand the concept of Pharmacy On-Demand and its role in R&D formulation.   • Explore how adaptive formulation strategies reduce development risk and conserve valuable API.   • Examine the impact of these approaches on first-in-human trials. Learn how flexible strategies streamline the transition from early-stage development to full-scale GMP manufacturing and commercialization. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿 Anthony James, Executive Director, Business Development, Altasciences